SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is trending due to positive trial results for its PoNS device in stroke rehabilitation, sparking community excitement about its potential FDA submission under Breakthrough Device Designation. The community is actively discussing the low float and potential for a short squeeze, while some caution about potential dilution. Broader context includes the company's focus on neuromodulation therapies and its existing FDA approval for multiple sclerosis.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending due to its dedicated community and consistent growth over the past nine months, setting new all-time highs. The community is energized by a current buy contest and anticipates increased exposure with an upcoming listing, as well as an airdrop. Many believe $BROKE.X is undervalued and poised for a significant breakout, emphasizing its resilience and potential in the altcoin space.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia ($NVDA) is trending amid news of China investigating potential antitrust violations related to a past acquisition, sparking concerns about market access and potential penalties. The community debates the significance of this development, with some viewing it as an opportunity to buy the dip while others express concerns about the stock's vulnerability to negative China-related headlines and potential broader market impacts. Despite the uncertainty, some remain optimistic about Nvidia's long-term prospects, citing its leadership in AI and strong fundamentals.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

aTyr Pharma is trending as traders anticipate the release of Phase 3 trial data for their lead drug, Efzofitimod, with potential implications for treating pulmonary sarcoidosis; the community is discussing possible outcomes and speculating on a short squeeze, while acknowledging the inherent risks of a binary biotech event; some are closely watching for early data leaks or unusual trading patterns, while others are reviewing past trial data and KOL opinions to inform their investment decisions.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors discuss its high short interest and potential for a squeeze, with some citing the upcoming Rumble Wallet launch and the Northern Data acquisition as possible catalysts. JD Vance's exclusive on the platform and overall ties to prominent figures are also fueling community speculation. Despite some frustration with the stock's performance, bulls remain optimistic about its long-term potential, particularly with its connections to crypto and a shift towards alternative media.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

Asset Entities Inc. ($ASST) is trending due to its recent merger with Strive and a strategic shift towards Bitcoin, sparking discussions of a potential short squeeze. The community is focused on high short interest, borrow fees, and the possibility of forced buy-ins, with many anticipating significant price movement. Some traders are experiencing trading restrictions, while others speculate on the impact of potential dilution from warrants.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending amid excitement surrounding upcoming presentations at the Quantum World Congress and UK regulatory approval for its acquisition of Oxford Ionics. The community is actively debating whether IONQ can achieve a market capitalization similar to that of NVDA, and many are citing the stock's potential for significant long-term gains while some discuss short-term profit taking.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla ($TSLA) is trending amid rising Q3 delivery expectations and increased energy storage discussion. Community chatter highlights Barclays raising delivery expectations, robotics potential, and the cult-like following the stock commands. Some caution remains due to ending tax credits and potential bank target revisions.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending due to positive sentiment around nuclear energy deals and potential entry into the US SMR market. Community members are discussing the UK's commitment to nuclear expansion and anticipating further news from upcoming industry events. Increased defense spending and potential partnerships related to AI data centers are also driving interest in the stock.

BlackRock Institutional Trust Company N.A. - iShares Semiconductor ETF

iShares Semiconductor ETF

SOXX is trending due to a mix of factors, including reactions to Nvidia's potential to resume AI chip sales in China and overall optimism in the semiconductor sector. Community discussions revolve around SOXX's technical indicators, potential pullbacks, and strategies involving leveraged ETFs like SOXL and SOXS. Broader market context includes the AI boom, geopolitical tensions, and upcoming earnings reports from major semiconductor companies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates

MiMedx (MDXG) delivered earnings and revenue surprises of +66.67% and +10.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending

Investing.com -- MiMedx Group (NASDAQ:MDXG) stock fell 19% and Organogenesis Holdings (NASDAQ:ORGO) shares plunged 36% after the Centers for Medicare&Medicaid Services (CMS) proposed a rule that would drastically cut Medicare spending on skin substitutes.

Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength?

MiMedx (MDXG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX 'PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE...

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES' THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES...

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

DEFENDANT FIGHTS BACK AGAINST MiMEDX 'BLATANT INTIMIDATION' NON-COMPETE SUIT DEFENDANT FIGHTS BACK AGAINST MiMEDX 'BLATANT INTIMIDATION' NON-COMPETE SUIT PR Newswire MARIETTA, Ga., Aug. 26, 2024...

Craig-Hallum Sticks to Its Buy Rating for MiMedx Group (MDXG)

Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on MiMedx Group (MDXG Research Report) today. The company's shares closed yester...

MIMEDX Provides Update on AXIOFILL  Request for Designation ( RFD ) from FDA

Receives Determination Letter from FDA Stating AXIOFILL Does Not Qualify for Classification as an HCT/P Under Section 361 MIMEDX Continues to Pursue All Available Options to Keep AXIOFILL on the...

MiMedx Group (MDXG, $7.83) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 25, 2024

This is a Bearish indicator signaling MDXG's price could decline from here. Traders may explore shorting the stock or put options...

MiMedx Group (MDXG, $8.03) entered Downtrend as Momentum indicator drops below 0 level on Mar 22, 2024

This indicator may be signaling that MDXG's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

MDXG
Mimedx Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MDXG News

MDXG Mimedx Group Inc